Scientists once hoped that blocking β-secretase would slow or prevent Alzheimer’s disease. Then came the rude awakening. The inhibitors caused the very thing they were supposed to prevent—cognitive ...

CHARLOTTE, NC--(Marketwired - Feb 17, 2015) - BACE, a global manufacturer of balers and compactors for the recycling and waste-disposal industries, has entered a strategic investment partnership with ...

What is the likelihood of BACE inhibitors providing clinical value to Alzheimer’s patients? originally appeared on Quora: the place to gain and share knowledge, empowering people to learn from others ...

The protein amyloid beta is believed to be the major cause of Alzheimer's disease. Substances that reduce the production of amyloid beta, such as BACE inhibitors, are therefore promising candidates ...

One of the last major, late-stage attempt at stopping Alzheimer’s disease (AD) using a BACE inhibitor has ended up on the trash pile with so many others. Earlier this year, Biogen and partner Eisai ...

JAM Capital Partners has agreed to make an investment in BACE, a Charlotte, North Carolina-based maker of balers and compactors for the recycling and waste-disposal sectors. No financial terms were ...

CHARLOTTE, NC--(Marketwired - May 2, 2014) - BACE, a global manufacturer of vertical balers and compactors for use in the recycling and waste management industry, has hired Gregory J. Leon to the ...

Immunotherapy, through either passive or active immunization, remains a viable and aggressively pursued strategy for ridding the brain of amyloid β, the major component found in the amyloid plaques ...

Over the past 15 years, many of the steps in the development of Alzheimer's disease have been elucidated. In particular, the emergence of the amyloid-β (Aβ) peptide as the central molecule in the ...

Verisae Inc., an Accruent company and a provider of cloud-based solutions that connect facilities and assets to the maintenance and service network, has announced that BACE has implemented its vx ...